Amendment history : Erratum ( May 2016 ) Matricellular protein CCN 3 mitigates abdominal aortic aneurysm

Abdominal aortic aneurysm (AAA) is a major cause of morbidity and mortality; however, the mechanisms that are involved in disease initiation and progression are incompletely understood. Extracellular matrix proteins play an integral role in modulating vascular homeostasis in health and disease. Here, we determined that the expression of the matricellular protein CCN3 is strongly reduced in rodent AAA models, including angiotensin II–induced AAA and elastase perfusion–stimulated AAA. CCN3 levels were also reduced in human AAA biopsies compared with those in controls. In murine models of induced AAA, germline deletion of Ccn3 resulted in severe phenotypes characterized by elastin fragmentation, vessel dilation, vascular inflammation, dissection, heightened ROS generation, and smooth muscle cell loss. Conversely, overexpression of CCN3 mitigated both elastaseand angiotensin II–induced AAA formation in mice. BM transplantation experiments suggested that the AAA phenotype of CCN3-deficient mice is intrinsic to the vasculature, as AAA was not exacerbated in WT animals that received CCN3-deficient BM and WT BM did not reduce AAA severity in CCN3-deficient mice. Genetic and pharmacological approaches implicated the ERK1/2 pathway as a critical regulator of CCN3-dependent AAA development. Together, these results demonstrate that CCN3 is a nodal [...] Research Article Vascular biology

[1]  Jay D. Humphrey,et al.  Mechanotransduction and extracellular matrix homeostasis , 2014, Nature Reviews Molecular Cell Biology.

[2]  V. Weaver,et al.  Extracellular matrix assembly: a multiscale deconstruction , 2014, Nature Reviews Molecular Cell Biology.

[3]  G. Shi,et al.  Vascular wall extracellular matrix proteins and vascular diseases. , 2014, Biochimica et biophysica acta.

[4]  Proteomic and genomic analyses suggest the association of apolipoprotein C1 with abdominal aortic aneurysm , 2014, Proteomics. Clinical applications.

[5]  A. Daugherty,et al.  Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies , 2014, Heart.

[6]  P. Libby,et al.  IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms , 2014, EMBO molecular medicine.

[7]  G. Upchurch,et al.  CARDIOVASCULAR , PULMONARY , AND RENAL PATHOLOGY Phosphorylation of AKT and Abdominal Aortic Aneurysm Formation , 2013 .

[8]  Shing‐Jong Lin,et al.  Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway. , 2013, Cardiovascular research.

[9]  J. Bavaria,et al.  Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm. , 2013, Cardiovascular research.

[10]  Heng Wan,et al.  CCN4 regulates vascular smooth muscle cell migration and proliferation , 2013, Molecules and cells.

[11]  A. Daugherty,et al.  Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms. , 2013, Current opinion in pharmacology.

[12]  J. Golledge,et al.  Everolimus Limits Aortic Aneurysm in the Apolipoprotein E–Deficient Mouse by Downregulating C-C Chemokine Receptor 2 Positive Monocytes , 2013, Arteriosclerosis, Thrombosis and Vascular Biology.

[13]  J. Golledge,et al.  Transforming growth factor-β and abdominal aortic aneurysms. , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[14]  B. Perbal CCN proteins: A centralized communication network , 2013, Journal of Cell Communication and Signaling.

[15]  J. Coselli,et al.  AKT2 Confers Protection Against Aortic Aneurysms and Dissections , 2013, Circulation research.

[16]  Karen Cheng,et al.  Loss of CDKN2B Promotes p53-Dependent Smooth Muscle Cell Apoptosis and Aneurysm Formation , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[17]  J. Coselli,et al.  Notch Signaling in Descending Thoracic Aortic Aneurysm and Dissection , 2012, PloS one.

[18]  R. Schwartz,et al.  Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function , 2012, Nature Medicine.

[19]  M. Eagleton,et al.  Local and systemic alterations in signal transducers and activators of transcription (STAT) associated with human abdominal aortic aneurysms. , 2012, The Journal of surgical research.

[20]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[21]  Cheng Zhang,et al.  Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo , 2012, Nature Medicine.

[22]  P. Tsao,et al.  MicroRNA-21 Blocks Abdominal Aortic Aneurysm Development and Nicotine-Augmented Expansion , 2012, Science Translational Medicine.

[23]  Alicia Deng,et al.  Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. , 2012, The Journal of clinical investigation.

[24]  Lester F. Lau,et al.  Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets , 2011, Nature Reviews Drug Discovery.

[25]  J. Redondo,et al.  Regulator of calcineurin 1 mediates pathological vascular wall remodeling , 2011, The Journal of experimental medicine.

[26]  R. Charnigo,et al.  Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. , 2011, The American journal of pathology.

[27]  J. Golledge,et al.  Current status of medical management for abdominal aortic aneurysm. , 2011, Atherosclerosis.

[28]  S. Lemaire,et al.  Epidemiology of thoracic aortic dissection , 2011, Nature Reviews Cardiology.

[29]  L. Rodella,et al.  Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension. , 2011, Human gene therapy.

[30]  J. Golledge,et al.  Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm. , 2010, Atherosclerosis.

[31]  Saptarsi M. Haldar,et al.  Klf15 Deficiency Is a Molecular Link Between Heart Failure and Aortic Aneurysm Formation , 2010, Science Translational Medicine.

[32]  Caili Hao,et al.  A novel role of CCN3 in regulating endothelial inflammation , 2010, Journal of Cell Communication and Signaling.

[33]  Magdi H. Yacoub,et al.  Cellular and molecular mechanisms of thoracic aortic aneurysms , 2009, Nature Reviews Cardiology.

[34]  P. Holt,et al.  Review of Current Theories for Abdominal Aortic Aneurysm Pathogenesis , 2009, Vascular.

[35]  N. Weintraub,et al.  Understanding abdominal aortic aneurysm. , 2009, The New England journal of medicine.

[36]  L. Lau,et al.  Functions and mechanisms of action of CCN matricellular proteins. , 2009, The international journal of biochemistry & cell biology.

[37]  A. Irvine,et al.  CCN3--a key regulator of the hematopoietic compartment. , 2009, Blood reviews.

[38]  下山 立志 CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration , 2009 .

[39]  W. Buurman,et al.  Biomarkers of AAA progression. Part 1: extracellular matrix degeneration , 2009, Nature Reviews Cardiology.

[40]  J. Golledge,et al.  Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm , 2009, BMC Genomics.

[41]  A. Boddy,et al.  Basic research studies to understand aneurysm disease. , 2008, Drug news & perspectives.

[42]  M. Halks-Miller,et al.  Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice , 2008, Gene Therapy.

[43]  H. Yeger,et al.  The CCN family of genes: a perspective on CCN biology and therapeutic potential , 2007, Journal of Cell Communication and Signaling.

[44]  松前 宏信 CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model , 2008 .

[45]  M. Aoki,et al.  Regression of Abdominal Aortic Aneurysms by Simultaneous Inhibition of Nuclear Factor &kgr;B and Ets in a Rabbit Model , 2007, Circulation research.

[46]  Gerard Tromp,et al.  Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms , 2007, BMC Genomics.

[47]  T. Enver,et al.  NOV (CCN3) Functions as a Regulator of Human Hematopoietic Stem or Progenitor Cells , 2007, Science.

[48]  N. Weintraub,et al.  Role of Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[49]  Peter Libby,et al.  Inflammation and cellular immune responses in abdominal aortic aneurysms. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[50]  R. Ricci,et al.  Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase , 2005, Nature Medicine.

[51]  M M Thompson,et al.  A review of biological factors implicated in abdominal aortic aneurysm rupture. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[52]  M. Halks-Miller,et al.  Fasudil, a Rho-Kinase Inhibitor, Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysm in Apolipoprotein E–Deficient Mice by Inhibiting Apoptosis and Proteolysis , 2005, Circulation.

[53]  Naoya Nakai,et al.  Essential role for ERK2 mitogen‐activated protein kinase in placental development , 2003, Genes to cells : devoted to molecular & cellular mechanisms.

[54]  L. Lau,et al.  CCN3 (NOV) Is a Novel Angiogenic Regulator of the CCN Protein Family* , 2003, Journal of Biological Chemistry.

[55]  L. Lau,et al.  Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. , 2002, Blood.

[56]  L. Lau,et al.  The Angiogenic Factor Cysteine-Rich 61 (CYR61, CCN1) Supports Vascular Smooth Muscle Cell Adhesion and Stimulates Chemotaxis through Integrin α6β1 and Cell Surface Heparan Sulfate Proteoglycans. , 2002, Endocrinology.

[57]  A. Daugherty,et al.  Antagonism of AT2 receptors augments Angiotensin II‐induced abdominal aortic aneurysms and atherosclerosis , 2001, British journal of pharmacology.

[58]  J. Sweatt,et al.  Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. , 2001, Learning & memory.

[59]  W. Fan,et al.  Connective tissue growth factor (CTGF) stimulates vascular smooth muscle cell growth and migration in vitro. , 2000, European journal of cell biology.

[60]  Qin Chen,et al.  Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[61]  S. Shapiro,et al.  Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. , 2000, The Journal of clinical investigation.

[62]  A Daugherty,et al.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.

[63]  L. Lau,et al.  Fisp12/Mouse Connective Tissue Growth Factor Mediates Endothelial Cell Adhesion and Migration through Integrin αvβ3, Promotes Endothelial Cell Survival, and Induces Angiogenesis In Vivo , 1999, Molecular and Cellular Biology.

[64]  P. Schofield,et al.  novH: differential expression in developing kidney and Wilm's tumors. , 1998, The American journal of pathology.

[65]  T. V. Kolesnikova,et al.  CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  W. März,et al.  Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. , 1997, Circulation.

[67]  V. Joliot,et al.  Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas , 1992, Molecular and cellular biology.